Total Payments
$117,071
2024 Payments
$997.74
Companies
9
Transactions
120
Medicare Patients
1,270
Medicare Billing
$132,662
Payment Breakdown by Category
Other$100,665 (86.0%)
Consulting$9,245 (7.9%)
Travel$4,608 (3.9%)
Food & Beverage$2,483 (2.1%)
Education$69.32 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100,665 | 40 | 86.0% |
| Consulting Fee | $9,245 | 3 | 7.9% |
| Travel and Lodging | $4,608 | 26 | 3.9% |
| Food and Beverage | $2,483 | 43 | 2.1% |
| Education | $69.32 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Acorda Therapeutics, Inc | $115,893 | 99 | $0 (2024) |
| Boston Scientific Corporation | $564.46 | 5 | $0 (2024) |
| Abbott Laboratories | $177.78 | 3 | $0 (2023) |
| Adamas Pharmaceuticals, Inc. | $166.44 | 6 | $0 (2018) |
| US WorldMeds, LLC | $81.26 | 1 | $0 (2019) |
| Amneal Pharmaceuticals LLC | $78.77 | 1 | $0 (2024) |
| Medtronic, Inc. | $54.78 | 3 | $0 (2024) |
| AbbVie, Inc. | $40.78 | 1 | $0 (2019) |
| Avion Pharmaceuticals | $13.62 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $997.74 | 5 | Acorda Therapeutics, Inc ($650.00) |
| 2023 | $8,036 | 15 | Acorda Therapeutics, Inc ($7,744) |
| 2022 | $3,583 | 4 | Acorda Therapeutics, Inc ($3,569) |
| 2021 | $23,897 | 13 | Acorda Therapeutics, Inc ($23,897) |
| 2020 | $6,048 | 15 | Acorda Therapeutics, Inc ($5,883) |
| 2019 | $74,342 | 62 | Acorda Therapeutics, Inc ($74,150) |
| 2018 | $166.44 | 6 | Adamas Pharmaceuticals, Inc. ($166.44) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $86.41 | General |
| Category: Vercise_NMD | ||||||
| 11/20/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $78.77 | General |
| Category: NEUROLOGY | ||||||
| 09/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $165.54 | General |
| Category: General - DBS_NMD | ||||||
| 06/03/2024 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Parkinson's Disease | ||||||
| 03/12/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/14/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,934.00 | General |
| Category: Parkinson's Disease | ||||||
| 11/14/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Travel and Lodging | Cash or cash equivalent | $192.57 | General |
| Category: Parkinson's Disease | ||||||
| 11/14/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Travel and Lodging | Cash or cash equivalent | $12.70 | General |
| Category: Parkinson's Disease | ||||||
| 11/01/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $978.00 | General |
| Category: Parkinson's Disease | ||||||
| 10/24/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Education | In-kind items and services | $8.13 | General |
| Category: Parkinson's Disease | ||||||
| 10/24/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Education | In-kind items and services | $6.32 | General |
| Category: Parkinson's Disease | ||||||
| 10/17/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $98.36 | General |
| Category: General - DBS_NMD | ||||||
| 08/30/2023 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 08/16/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $489.00 | General |
| Category: Parkinson's Disease | ||||||
| 08/07/2023 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 08/02/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Neuromodulation | ||||||
| 06/06/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Education | In-kind items and services | $8.13 | General |
| Category: Parkinson's Disease | ||||||
| 04/26/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,934.00 | General |
| Category: Parkinson's Disease | ||||||
| 04/26/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Travel and Lodging | Cash or cash equivalent | $180.78 | General |
| Category: Parkinson's Disease | ||||||
| 04/05/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $143.62 | General |
| Category: General - DBS_NMD | ||||||
| 07/06/2022 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Travel and Lodging | Cash or cash equivalent | $146.25 | General |
| Category: Parkinson's Disease | ||||||
| 06/27/2022 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,934.00 | General |
| Category: Parkinson's Disease | ||||||
| 05/06/2022 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $489.00 | General |
| Category: Parkinson's Disease | ||||||
| 03/03/2022 | Avion Pharmaceuticals | Dhivy (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Parkinson's disease | ||||||
| 10/28/2021 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: PARKINSONS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 358 | 570 | $177,591 | $38,671 |
| 2022 | 5 | 265 | 391 | $128,643 | $29,001 |
| 2021 | 8 | 348 | 514 | $132,849 | $38,374 |
| 2020 | 9 | 299 | 482 | $120,056 | $26,616 |
Total Patients
1,270
Total Services
1,957
Medicare Billing
$132,662
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 98 | 156 | $66,268 | $14,070 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 104 | 138 | $38,644 | $8,722 | 22.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 14 | 41 | $24,726 | $4,120 | 16.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 67 | $14,338 | $4,059 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 29 | 29 | $15,613 | $3,589 | 23.0% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Facility | 2023 | 22 | 49 | $7,301 | $1,514 | 20.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 17 | $5,083 | $1,013 | 19.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 23 | $2,668 | $872.16 | 32.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 16 | 50 | $2,950 | $712.80 | 24.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 93 | 137 | $59,422 | $13,238 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 95 | 124 | $36,896 | $8,017 | 21.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 30 | 30 | $16,350 | $3,624 | 22.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 65 | $13,910 | $3,599 | 25.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 13 | 35 | $2,065 | $524.00 | 25.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 96 | 167 | $51,248 | $16,557 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 94 | 121 | $28,793 | $8,470 | 29.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 43 | 43 | $20,855 | $5,900 | 28.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 78 | $16,692 | $3,694 | 22.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 26 | $8,034 | $2,055 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 17 | 17 | $2,687 | $606.77 | 22.6% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2021 | 17 | 40 | $2,400 | $581.64 | 24.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 15 | 22 | $2,140 | $509.27 | 23.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 120 | 196 | $47,588 | $10,005 | 21.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 46 | 53 | $16,472 | $4,355 | 26.4% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2020 | 11 | 32 | $18,450 | $3,360 | 18.2% |
About Dr. Jennifer Durphy, M.D
Dr. Jennifer Durphy, M.D is a Neurology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295927952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Durphy, M.D has received a total of $117,071 in payments from pharmaceutical and medical device companies, with $997.74 received in 2024. These payments were reported across 120 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($100,665).
As a Medicare-enrolled provider, Durphy has provided services to 1,270 Medicare beneficiaries, totaling 1,957 services with total Medicare billing of $132,662. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Albany, NY
- Active Since 08/15/2007
- Last Updated 05/21/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1295927952
Products in Payments
- INBRIJA (Drug) $109,562
- GOCOVRI (Drug) $166.44
- Infinity DBS Pulse Generators (Device) $164.66
- Vercise (Device) $86.41
- APOKYN (Drug) $81.26
- CREXONT (Drug) $78.77
- VERCISE (Device) $70.53
- PERCEPT PC BRAINSENSE (Device) $54.78
- Duopa (Drug) $40.78
- Dhivy (Drug) $13.62
- INFINITY (Device) $13.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Albany
Charles Argoff, Md, MD
Neurology — Payments: $1.6M
Neurology $1.6M
Mrs. Angela Applebee, M.d, M.D
Neurology — Payments: $690,780
Neurology $690,780
Dr. Krupa Pandey, M.d, M.D
Neurology — Payments: $611,544
Neurology $611,544
Dr. Stanley Penc, Md Phd, MD PHD
Neurology — Payments: $552,076
Neurology $552,076
Dr. Timothy Lynch, Md, MD
Neurology — Payments: $273,946
Neurology $273,946
Richard Holub, Md, MD
Neurology — Payments: $113,635
Neurology $113,635